The article presents an analysis of the prevalence of anxiety and depression in people with obstructive ventilation disorders based on the results of the RESPECT population study (RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related aetiology). The findings indicate a high prevalence of subclinical and clinical anxiety (18.4%) or depression (21.3%) among people with persistent obstructive ventilation disorders. People with such disorders have been inclined to show more severe health problems and a lower self-esteem for their health.
The article addresses to changes in the management of patients with bronchial asthma in accordance with international and national recommendations of 2019. The new management strategy for patients with mild asthma, the rejection of short-acting 2-agonist (SABA) reliever medication monotherapy in favor of an anti-inflammatory bronchodilator drug will improve disease control, patient compliance, reduce the risk of severe exacerbations and death. The use of the algorithm for diagnosing and management asthma by primary care physicians, developed by experts of the Russian Respiratory Society and the Russian Association of Allergologists and Clinical Immunologists, will reduce the time for diagnosing asthma, timely and correctly prescribe anti-inflammatory therapy and control the course of the disease.
ФГБОУ ВО «Северо-Западный государственный медицинский университет имени И.И. Мечникова» Минздрава России, Санкт-Петербург, Россия © Коллектив авторов, 2018В статье представлены результаты ретроспективного исследования, направленного на выявление обострений у амбулаторных пациентов с хронической обструктивной болезнью легких (ХОБЛ) в те-чение предшествующих 12 месяцев. Для этого был проведен телефонный опрос 20 пациентов с ХОБЛ из отделений общей врачебной практики трех поликлиник Калининского района Санкт-Петербурга. Полученные данные были сопоставлены с записями в амбулаторных картах для определения наличия зарегистрированных случаев обращений в поликлинику по поводу обострения заболевания. По дан-ным опроса, 7 человек (35 %) можно отнести к фенотипу ХОБЛ с частыми обострениями. У 5 человек (33 %) из тех, кто не лечился в стационаре по поводу обострения ХОБЛ в предшествующие 12 мес., были отмечены косвенные признаки недооценки тяжести своего состояния, что свидетельствует о не-обходимости повышения информированности пациентов об обострениях ХОБЛ и обучения их навыкам самоконтроля.Ключевые слова: ХОБЛ; обострение; распространенность. The article presents the results of a retrospective study aimed at identifying exacerbations in outpatients with chronic obstructive pulmonary disease (COPD) during the previous 12 months. А telephone interview was conducted with 20 patients with COPD from the departments of general medical practice of three polyclinics in the Kalininsky district of St. Petersburg. The obtained data were compared with records in outpatient cards to determine the presence of registered cases of appeals to the polyclinic for exacerbation of the disease. DETECTION OF EXACERBACTIONS OF CHRONIC OBSTRUCTIVE LUNG DISEASE7 patients (35%) were identified retrospectively using the questionnaire, which can be attributed to the phenotype of COPD with frequent exacerbations. Among them, five people were hospitalized in a hospital for exacerbation of COPD, and two patients had 2 or more exacerbations in an outpatient card that did not lead to hospitalization. In 5 patients (33%), among those who were not in hospital for an exacerbation of COPD for the previous 12 months, indirect signs of low self-esteem were revealed, indicating that it is necessary to raise awareness of the exacerbation of COPD and the education patients self-management skills.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.